Association of sodium‐glucose cotransporter‐2 inhibitors with outcomes in type 2 diabetes with reduced and preserved left ventricular ejection fraction: Analysis from the CVD‐REAL 2 study

This study of real‐world data from the Maccabi database in Israel compared the risk of heart failure hospitalization (HHF) or death in patients with type 2 diabetes (T2D) initiating sodium‐glucose cotransporter‐2 (SGLT2) inhibitors versus other glucose‐lowering drugs (OGLDs) according to baseline le...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Carolyn S. P., Karasik, Avraham, Melzer‐Cohen, Cheli, Cavender, Matthew A., Kohsaka, Shun, Norhammar, Anna, Thuresson, Marcus, Chen, Hungta, Wittbrodt, Eric, Fenici, Peter, Kosiborod, Mikhail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251980/
https://www.ncbi.nlm.nih.gov/pubmed/33606906
http://dx.doi.org/10.1111/dom.14356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251980/
https://www.ncbi.nlm.nih.gov/pubmed/33606906
http://dx.doi.org/10.1111/dom.14356

Ejemplares similares